Synlogic is a pioneering brand at the forefront of transforming biotherapeutics for patients. Combining biology and engineering, Synlogic uses synthetic biology to design living medicines that are programmed to treat diseases in innovative ways. Their synthetic biotics, a novel type of biotherapeutic, target the underlying drivers of disease, offering new hope and transforming treatment paradigms.

With a strong pipeline of potential therapies, Synlogic's team is driven by the promise of synthetic biology and the new possibilities it brings for better health. Located in Cambridge, MA, Synlogic is a leading company in advancing therapeutics based on synthetic biology. With their commitment to clinical trials and collaborations, they are dedicated to designing purposeful solutions to address unmet medical needs.

Stay connected and receive updates on Synlogic's clinical trials by signing up on their website